Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Lheureux

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
International Journal of Women'S Health|January 4, 2023
Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management ChallengesEduardo Gonzalez-Ochoa, Husam A Alqaisi, Gita Bhat, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Non-target progression--the fine line between objectivity and subjectivityStephanie Lheureux, Michelle K Wilson, Martin O'Malley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Can we learn from failures? A systematic review of phase III trials in platinum-resistant ovarian cancerFederica Martorana, Giuliana Pavone, Cristiana Sessa, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Paradigm Shift in the Management Strategy for Epithelial Ovarian CancerKeiichi Fujiwara, Jessica N McAlpine, Stephanie Lheureux, et al.
Frontiers in Oncology|June 1, 2016
Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionKatherine Karakasis, Julia V Burnier, Valerie Bowering, et al.
Therapeutic Advances in Medical Oncology|March 6, 2023
Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancerAna C Veneziani, Clare Scott, Matthew J Wakefield, et al.
Gynecologic Oncology|May 12, 2024
Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinomaSabrina Piedimonte, Ciara Murray, Eshetu G Atenafu, et al.
Methods (San Diego, Calif.)|July 27, 2017
Molecular imaging in drug development: Update and challenges for radiolabeled antibodies and nanotechnologyIlaria Colombo, Marta Overchuk, Juan Chen, et al.
Current Oncology (Toronto, Ont.)|January 27, 2021
Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the LiteratureLawrence Kasherman, Jeffrey Doi, Katherine Karakasis, et al.
Gynecologic Oncology|February 23, 2017
Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysisJosee-Lyne Ethier, Danielle N Desautels, Arnoud J Templeton, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
International Journal of Women'S Health|January 4, 2023
Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management ChallengesEduardo Gonzalez-Ochoa, Husam A Alqaisi, Gita Bhat, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Non-target progression--the fine line between objectivity and subjectivityStephanie Lheureux, Michelle K Wilson, Martin O'Malley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Can we learn from failures? A systematic review of phase III trials in platinum-resistant ovarian cancerFederica Martorana, Giuliana Pavone, Cristiana Sessa, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Paradigm Shift in the Management Strategy for Epithelial Ovarian CancerKeiichi Fujiwara, Jessica N McAlpine, Stephanie Lheureux, et al.
Frontiers in Oncology|June 1, 2016
Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionKatherine Karakasis, Julia V Burnier, Valerie Bowering, et al.
Therapeutic Advances in Medical Oncology|March 6, 2023
Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancerAna C Veneziani, Clare Scott, Matthew J Wakefield, et al.
Gynecologic Oncology|May 12, 2024
Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinomaSabrina Piedimonte, Ciara Murray, Eshetu G Atenafu, et al.
Methods (San Diego, Calif.)|July 27, 2017
Molecular imaging in drug development: Update and challenges for radiolabeled antibodies and nanotechnologyIlaria Colombo, Marta Overchuk, Juan Chen, et al.
Current Oncology (Toronto, Ont.)|January 27, 2021
Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the LiteratureLawrence Kasherman, Jeffrey Doi, Katherine Karakasis, et al.
Gynecologic Oncology|February 23, 2017
Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysisJosee-Lyne Ethier, Danielle N Desautels, Arnoud J Templeton, et al.
Pageof 15